Company / Shares Outstanding
Akebia Therapeutics, Inc. Shares Outstanding History
FY2014-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
224.8M
FY2025
5-year range
148.1M / 224.8M
FY2021-FY2025
Trend
+15.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Shares Outstanding has increased for 9 consecutive years, from 1383345.00 in FY2014 to 224848992.00 in FY2025.
Based on SEC 10-K filings.
224848992.00 in FY2025 with a 10-year CAGR of +27.1%.
Increased from 184135714.00 to 224848992.00 over the past 2 years.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +8.3%
- 5-Year CAGR
- +13.1%
- 10-Year CAGR
- +27.1%
Key checks
Key Insights
- Akebia Therapeutics, Inc.'s shares outstanding has grown for 9 consecutive years.
- In FY2025, shares outstanding increased 15.6% year-over-year.
- Lowest shares outstanding in the period was in FY2014.
Company context
Key Data Points
- Altman Z-Score -2.76 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | 224.8M | +15.6% |
| FY2024 | 194.6M | +5.7% |
| FY2023 | 184.1M | +4.0% |
| FY2022 | 177.0M | +19.5% |
| FY2021 | 148.1M | +21.7% |
| FY2020 | 121.7M | +4.1% |
| FY2019 | 116.9M | +145.5% |
| FY2018 | 47.6M | +133.7% |
| FY2015 | 20.4M | +1372.6% |
| FY2014 | 1.4M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026